Analysts Set Expectations for ELEV FY2029 Earnings
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Equities researchers at HC Wainwright issued their FY2029 earnings estimates for Elevation Oncology in a research report issued to clients and investors on Friday, March 21st. HC Wainwright analyst S. Ramakanth forecasts that the company will post earnings of ($0.40) per share for the year. HC Wainwright […]
